US Pharma MarketingFDA taps Lilly, Fujifilm and five more for its factory-speeding PreCheck pilot
FDA picks Eli Lilly, Regeneron, Fujifilm, Cellares, Amneal, Kriya and Kyowa Kirin for its PreCheck pilot to speed US manufacturing reviews ahead of drug approvals. Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing: Scaling the next frontier China biotech: Licensing deals and the Biosecure Act CRISPR and gene…
The FDA has chosen the first seven companies to participate in its pilot PreCheck program, a group that includes large drugmakers Eli Lilly and Regeneron and manufacturers Cellares and Fujifilm.
Kriya Therapeutics, Amneal Pharmaceuticals and ...
Source: Endpoints News